US Stock MarketDetailed Quotes

NVS Novartis AG

Watchlist

99.970
-0.060-0.06%

Close Jan 24 16:00 ET

99.970
0.0000.00%

Post 20:01 ET

199.87BMarket Cap11.73P/E (TTM)

Novartis AG Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Novartis AG Q4 2024 Estimates Date

Currency：USDJan 31, 2025

	Estimate	YoY
Revenue	12.77B	+11.75%
EPS	1.04	-74.84%

Analyst Rating

Buy

Dec 31, 2024

Novartis AG Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 12.559B	--
Jan 31, 2025	2024/Q4	-- / 12.765B	--
Oct 29, 2024	2024/Q3	12.823B / 12.666B	--
Jul 18, 2024	2024/Q2	12.512B / 12.319B	--
Apr 23, 2024	2024/Q1	11.829B / 11.498B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 12.559B--

Jan 31, 20252024/Q4-- / 12.765B--

Oct 29, 20242024/Q312.823B / 12.666B--

Jul 18, 20242024/Q212.512B / 12.319B--

Apr 23, 20242024/Q111.829B / 11.498B--

Unlock Free Earnings Estimates

Open Account

Novartis AG Earnings Reports

6-K: Novartis Upgrades Mid-Term Guidance

Nov 25, 2024 10:22 ET

6-K: Financial Report Q3 2024

Oct 29, 2024 06:23 ET

6-K: Explanatory Note

Sep 18, 2024 16:42 ET

6-K: Novartis Second Quarter and Half Year 2024 Condensed Interim Financial Report – Supplementary Data

Jul 18, 2024 06:11 ET